JW Pharmaceutical Co., Ltd. Preferred Stock (001065) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for JW Pharmaceutical Co., Ltd. Preferred Stock (001065:KRX), powered by AI.

Current Price
₩21,050
P/E Ratio
0.1
Market Cap
7.2B
Sector
Healthcare
What is the JW Pharmaceutical Co., Ltd. Preferred Stock stock price forecast?

JW Pharmaceutical Co., Ltd. Preferred Stock is currently trading at ₩21,050. View real-time AI analysis on Alpha Lenz.

What is JW Pharmaceutical Co., Ltd. Preferred Stock insider trading activity?

View the latest insider trading data for JW Pharmaceutical Co., Ltd. Preferred Stock on Alpha Lenz.

What is JW Pharmaceutical Co., Ltd. Preferred Stock's P/E ratio?

JW Pharmaceutical Co., Ltd. Preferred Stock's P/E ratio is 0.1.

JW Pharmaceutical Co., Ltd. Preferred Stock

KRX · 001065
₩21,050-100(-0.47%)Market closedKRX regular session 09:00–15:30 KST
Ask about JW Pharmaceutical Co., Ltd. Preferred Stock's future dividend policy...
Alpha Chat Insight

JW Pharmaceutical Co., Ltd. Preferred Stock trades at a P/E of 0.1 (undervalued) with strong ROE of 17.6%.

Ask for details

Company Overview

JW Pharmaceutical Co., Ltd. Preferred Stock is a type of equity security that represents a claim on the company's assets and earnings. Unlike common stock, preferred stock typically comes with no voting rights, but it may offer greater dividend security in the form of fixed periodic dividend payments. This makes it an attractive option for those seeking a more stable income stream compared to common stock. JW Pharmaceutical operates in the pharmaceutical sector, focusing on developing, manufacturing, and distributing various medicines, which positions it in a critical and continuously evolving industry. Preferred stocks like those issued by JW Pharmaceutical are often seen as a hybrid between bonds and common stocks, providing elements of both equity growth and fixed income. In the financial market, this type of asset serves as a tool for diversifying investment portfolios, balancing the risk, and aiding in income generation, particularly in sectors that are essential and demonstrate resilience in various economic climates.

CEOMr. Young-Sub Shin
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,048

Company Statistics

FY 2025

Profile

₩7,198,068,550Market Cap
₩775,298,057,920Revenue
341.95KShares Out
1,048Employees

Margins

46.35%Gross
15.35%EBITDA
12.18%Operating
11.46%Pre-Tax
7.93%Net

Valuation

0.12P/E
0.02P/B
0.01EV/Sales
0.19EV/EBITDA
0.12P/FCF

Growth (CAGR)

4.25%Rev 3Yr
7.21%Rev 5Yr
14.59%Op Inc 3Yr
N/AOp Inc 5Yr
27.25%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

10.17%ROA
17.60%ROE
15.42%ROIC

Financial Health

₩39,232,537,850Cash & Cash Equivalents
₩196,671,029,850Net Debt
63.87%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

JW Pharmaceutical Co., Ltd. Preferred Stock (ticker: 001065) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,048 employees. Market cap is $7.2B.

The current price is ₩21,050 with a P/E ratio of 0.12x and P/B of 0.02x.

ROE is 17.60% and operating margin is 12.18%. Annual revenue is $775.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
JW Pharmaceutical Co., Ltd. Preferred Stock (001065) Stock Forecast 2026 ₩21,050 — Price, Financials & Analyst Targets | Alpha Lenz